ProShare Advisors LLC boosted its stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 3.8% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 225,898 shares of the semiconductor company’s stock after purchasing an additional 8,358 shares during the quarter. ProShare Advisors LLC owned about 0.12% of Synopsys worth $98,252,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds have also bought and sold shares of SNPS. BlackRock Inc. purchased a new stake in shares of Synopsys during the 2nd quarter valued at $7,228,099,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Synopsys in the second quarter worth $747,400,000. Bank of New York Mellon Corp purchased a new position in Synopsys in the second quarter worth $692,074,000. Bank of America Corp DE bought a new position in Synopsys in the second quarter valued at $539,986,000. Finally, Legal & General Group Plc bought a new position in Synopsys in the second quarter valued at $491,923,000. 85.47% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several equities research analysts have issued reports on the company. Robert W. Baird raised Synopsys from a “neutral” rating to an “outperform” rating and lifted their price target for the stock from $558.00 to $560.00 in a research note on Thursday, August 27th. Roth Capital upgraded Synopsys to a “buy” rating in a research report on Friday, September 25th. Rosenblatt Securities raised their price objective on Synopsys from $575.00 to $620.00 and gave the company a “buy” rating in a report on Thursday, October 1st. Sanford C. Bernstein started coverage on Synopsys in a research report on Friday, September 25th. They issued an “outperform” rating for the company. Finally, JPMorgan Chase & Co. cut their target price on Synopsys from $650.00 to $600.00 in a research note on Thursday, August 27th. One investment analyst has rated the stock with a Strong Buy rating, twenty-two have assigned a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Synopsys currently has a consensus rating of “Moderate Buy” and an average price target of $575.00.
Read Our Latest Stock Report on Synopsys
Synopsys Stock Performance
NASDAQ SNPS opened at $467.61 on Monday. The company has a 50-day simple moving average of $437.48 and a two-hundred day simple moving average of $443.62. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29. Synopsys, Inc. has a 12-month low of $362.55 and a 12-month high of $539.48. The firm has a market cap of $89.61 billion, a price-to-earnings ratio of 82.62, a PEG ratio of 1.90 and a beta of 1.18.
Synopsys (NASDAQ:SNPS – Get Free Report) last released its quarterly earnings data on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, topping the consensus estimate of $3.67 by $0.24. The firm had revenue of $2.48 billion for the quarter, compared to the consensus estimate of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The company’s quarterly revenue was up 42.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.39 earnings per share. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities analysts forecast that Synopsys, Inc. will post 11.01 EPS for the current year.
Synopsys declared that its board has initiated a share repurchase plan on Monday, October 5th that permits the company to buy back $1 billion in outstanding shares. This repurchase authorization permits the semiconductor company to repurchase up to 1.1% of its shares through open market purchases. Stock repurchase plans are often a sign that the company’s management believes its shares are undervalued.
Insider Buying and Selling
In related news, CEO Sassine Ghazi sold 14,604 shares of Synopsys stock in a transaction on Thursday, October 15th. The shares were sold at an average price of $462.84, for a total value of $6,759,315.36. Following the transaction, the chief executive officer directly owned 76,865 shares of the company’s stock, valued at $35,576,196.60. The trade was a 15.97% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Janet Lee sold 1,144 shares of the company’s stock in a transaction on Tuesday, October 6th. The shares were sold at an average price of $502.52, for a total transaction of $574,882.88. Following the sale, the insider owned 16,534 shares of the company’s stock, valued at $8,308,665.68. This represents a 6.47% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 117,163 shares of company stock worth $51,366,457. Company insiders own 0.56% of the company’s stock.
About Synopsys
Synopsys, Inc is an electronic design automation (EDA) and semiconductor intellectual property company serving the global semiconductor and electronics industries. Its software helps engineers design, verify, test and manufacture advanced integrated circuits and electronic systems.
The company’s products and services support digital and analog design, functional verification, design-for-test, manufacturing and semiconductor engineering workflows. Synopsys also provides reusable semiconductor IP, including processor cores, interface technologies, security solutions and other components used in system-on-chip designs.
In addition to its semiconductor design offerings, Synopsys provides software development and application security tools intended to help organizations identify and manage vulnerabilities and risks across the software development lifecycle.
Featured Articles
- Five stocks we like better than Synopsys
- STMicroelectronics Could Reach New Highs—Here’s What Needs to Happen
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
